1. Home
  2. WEAV vs DNA Comparison

WEAV vs DNA Comparison

Compare WEAV & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WEAV
  • DNA
  • Stock Information
  • Founded
  • WEAV 2011
  • DNA 2008
  • Country
  • WEAV United States
  • DNA United States
  • Employees
  • WEAV N/A
  • DNA N/A
  • Industry
  • WEAV EDP Services
  • DNA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • WEAV Technology
  • DNA Health Care
  • Exchange
  • WEAV Nasdaq
  • DNA Nasdaq
  • Market Cap
  • WEAV 650.3M
  • DNA 552.0M
  • IPO Year
  • WEAV 2021
  • DNA N/A
  • Fundamental
  • Price
  • WEAV $7.74
  • DNA $13.95
  • Analyst Decision
  • WEAV Strong Buy
  • DNA Hold
  • Analyst Count
  • WEAV 5
  • DNA 2
  • Target Price
  • WEAV $16.10
  • DNA $8.50
  • AVG Volume (30 Days)
  • WEAV 1.0M
  • DNA 2.1M
  • Earning Date
  • WEAV 07-31-2025
  • DNA 08-07-2025
  • Dividend Yield
  • WEAV N/A
  • DNA N/A
  • EPS Growth
  • WEAV N/A
  • DNA N/A
  • EPS
  • WEAV N/A
  • DNA N/A
  • Revenue
  • WEAV $212,950,000.00
  • DNA $237,417,000.00
  • Revenue This Year
  • WEAV $18.69
  • DNA N/A
  • Revenue Next Year
  • WEAV $15.71
  • DNA $15.91
  • P/E Ratio
  • WEAV N/A
  • DNA N/A
  • Revenue Growth
  • WEAV 19.58
  • DNA 13.76
  • 52 Week Low
  • WEAV $7.25
  • DNA $5.00
  • 52 Week High
  • WEAV $17.63
  • DNA $16.85
  • Technical
  • Relative Strength Index (RSI)
  • WEAV 40.45
  • DNA 68.25
  • Support Level
  • WEAV $7.25
  • DNA $9.27
  • Resistance Level
  • WEAV $8.28
  • DNA $15.48
  • Average True Range (ATR)
  • WEAV 0.33
  • DNA 1.06
  • MACD
  • WEAV 0.05
  • DNA 0.36
  • Stochastic Oscillator
  • WEAV 29.04
  • DNA 75.36

About WEAV Weave Communications Inc.

Weave Communications Inc is a customer experience and payments software platform tailored for SMB healthcare businesses, that revolutionizes patient interaction from initial contact to billing. It integrates diverse workflows into a unified solution, minimizing manual tasks and maximizing patient engagement. Weave democratizes enterprise-level communication tools, simplifying them for SMBs in a singular platform. Offering varied communication channels, appointment scheduling, payment processing, and more, enhances practitioner-patient relationships and optimizes practice operations. The company has a singular operating segment and revenue primarily from subscription services.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: